Indisetron
Alternative Names: N-3389; SinseronLatest Information Update: 31 Jul 2007
At a glance
- Originator Nisshin Pharma
- Developer Kyorin Pharmaceutical
- Class Antiemetics; Organic bridged compounds; Pyrazoles; Small molecules
- Mechanism of Action Serotonin 3 receptor antagonists; Serotonin 4 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Nausea and vomiting
Most Recent Events
- 20 Sep 2004 Launched for Nausea and vomiting in Japan (PO)
- 26 Aug 2004 Nisshin formed a cooperative sales agreement with Yakult Honsha for indisetron
- 11 Sep 2000 Phase-II clinical trials for Nausea and vomiting in Japan (IV)